Kumar Aditi, Cole Alexander, Segal Jonathan, Smith Philip, Limdi Jimmy K
Gastroenterology Department, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK.
Imperial College Healthcare NHS Trust, London, UK.
Therap Adv Gastroenterol. 2022 Feb 17;15:17562848221078456. doi: 10.1177/17562848221078456. eCollection 2022.
Crohn's disease is a chronic inflammatory, relapsing-remitting, and progressive gastrointestinal disorder with an often-negative impact on the physical, emotional, and psychological well-being. Over the past two decades, the medical compendium for the treatment of Crohn's disease has increased significantly, enabling treatment beyond symptoms. Indeed, early and timely use of effective medical therapy has been reflected by improved outcomes with reduction in surgery and ability to achieve clinical and endoscopic remission, reduce corticosteroid dependance, and prevent long-term complications in more patients. In this review, we discuss the key milestones in the medical management of Crohn's disease.
克罗恩病是一种慢性炎症性、复发缓解型且进行性的胃肠道疾病,对身体、情感和心理健康往往产生负面影响。在过去二十年中,治疗克罗恩病的医学纲要显著增加,使得治疗不再局限于症状缓解。事实上,早期及时使用有效的药物治疗已体现在改善的治疗效果上,包括手术减少、实现临床和内镜缓解的能力提高、减少皮质类固醇依赖以及预防更多患者出现长期并发症。在本综述中,我们讨论了克罗恩病药物治疗的关键里程碑。